LifeMD Inc (NASDAQ:LFMD)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 1.22. At the close of trading, the stock’s price was $4.83, to imply an increase of 3.21% or $0.15 in intraday trading. The LFMD share’s 52-week high remains $12.88, putting it -166.67% down since that peak but still an impressive 5.18% since price per share fell to its 52-week low of $4.58. The company has a valuation of $208.03M, with an average of 0.59 million shares in intraday trading volume over the past 10 days and average of 534.64K shares over the past 3 months.

Analysts have given a consensus recommendation of Buy for LifeMD Inc (LFMD), translating to a mean rating of 1.00. Of 4 analyst(s) looking at the stock, 0 analyst(s) give LFMD a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 4 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.12.

LifeMD Inc (NASDAQ:LFMD) trade information

After registering a 3.21% upside in the last session, LifeMD Inc (LFMD) has traded red over the past five days. The 5-day price performance for the stock is -7.29%, and -2.23% over 30 days. With these gigs, the year-to-date price performance is -41.74%. Short interest in LifeMD Inc (NASDAQ:LFMD) saw shorts transact 4.7 million shares and set a 11.07 days time to cover.

The extremes give us $12 and $14 for target low and target high price respectively. As such, LFMD has been trading -189.86% off suggested target high and -148.45% from its likely low.

LifeMD Inc (LFMD) estimates and forecasts

Looking at statistics comparing LifeMD Inc share performance against respective industry, we note that the company has outperformed competitors. LifeMD Inc (LFMD) shares are -49.58% down over the last 6 months, with its year-to-date growth rate higher than industry average at 30.00% against 7.30%. Revenue is forecast to grow 40.00% this quarter before jumping 66.70% for the next one. The rating firms project that company’s revenue will grow 35.00% compared to the previous financial year.

Revenue forecast for the current quarter as set by 7 analysts is 53.8M. Meanwhile, for the current quarter, a total of 7 analyst(s) estimate revenue growth to 57.34M.Earnings reports from the last fiscal year show that sales brought in 38.61M and 44.86M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 39.30% before jumping 27.80% in the following quarter.

LFMD Dividends

LifeMD Inc has its next earnings report out on 2024-Nov-06. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

LifeMD Inc (NASDAQ:LFMD)’s Major holders

LifeMD Inc insiders hold 15.57% of total outstanding shares, with institutional holders owning 38.46% of the shares at 45.55% float percentage. In total, 38.46% institutions holds shares in the company, led by BLACKROCK INC.. As of 2024-06-30, the company held over 2.34 million shares (or 5.9546% of shares), all amounting to roughly $16.03 million.

The next major institution holding the largest number of shares is VANGUARD GROUP INC with 1.52 million shares, or about 3.8697% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $10.42 million.

We also have iShares Russell 2000 ETF and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the LifeMD Inc (LFMD) shares. Going by data provided on Aug 31, 2024 , iShares Russell 2000 ETF holds roughly 918.31 shares. This is just over 2.13% of the total shares, with a market valuation of $4.44 million. Data from the same date shows that the other fund manager holds a little less at 838.53, or 1.95% of the shares, all valued at about 4.05 million.